Raymond James Financial’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
Raymond James Financial's IMVT Position: Q3 2026 in Review
Raymond James Financial sold out of Immunovant (IMVT) in Q3 2026, closing a stake of 5,758 shares — an estimated $222K sold.
Raymond James Financial first reported a position in IMVT in Q4 2024 and held it in 5 quarters. The position peaked at $1.02M in Q1 2025. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- Raymond James Financial reported no remaining Immunovant position as of Q3 2026 after selling out during the quarter.
- Raymond James Financial sold 5,758 Immunovant shares in Q3 2026, an estimated $222K.
- Raymond James Financial first reported a position in Immunovant in Q4 2024 and held it in 5 quarters.
- Raymond James Financial's Immunovant position peaked at $1.02M in Q1 2025.
- 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.